By Angela Chen 

AmerisourceBergen Corp. said Wednesday that its revenue rose 15% in the December quarter, buoyed by strong demand for its specialty products and gains from its collaboration with Walgreen Boots Alliance Inc.

Results beat expectations, sending shares up about 3% in premarket trading.

The company also raised its earnings outlook for the year ending in September to $4.45 to $4.55 a share, up from its previous range of $4.36 to $4.50 a share.

Drug wholesalers like AmerisourceBergen have been forming ventures and collaborations with other health-care related companies to increase their bargaining power with pharmaceutical companies. In 2013, AmerisourceBergen began an alliance with U.S. drugstore-chain operator Walgreen and European drug giant Alliance Boots GmbH, which have since merged.

Earlier this month, the company agreed to buy MWI Veterinary Supply Inc. for $2.5 billion, expanding into the growing area of animal health.

In its fiscal first quarter, pharmaceutical distribution revenue grew 15% to $33 billion, primarily due to the new Walgreen generic-pharmaceutical business, strong sales of hepatitis C products, and organic sales growth in its health systems and alternate-site customers. Within the segment, the specialty group saw revenue grow 26% due to good performance in the blood products category and increases in sales to community oncology practices.

Nonpharmaceutical revenue also grew 15%, mostly due to demand for the company's consulting business.

Overall, AmerisourceBergen reported a loss of $200 million, or 91 cents a share, compared with a profit of $41.3 million, or 17 cents a share, a year earlier.

Excluding special items including those related to the MWI transaction, earnings rose to $1.14 a share from 80 cents the year before.

Revenue grew to $33.6 billion.

Analysts polled by Thomson Reuters had expected per-share earnings of 97 cents and revenue of $31.6 billion.

Shares of AmerisourceBergen have risen 42% in the past 12 months as of Tuesday's close.

Write to Angela Chen at angela.chen@dowjones.com

Access Investor Kit for AmerisourceBergen Corp.

Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US03073E1055

Access Investor Kit for MWI Veterinary Supply, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US55402X1054

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Mwi Veterinary (NASDAQ:MWIV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Mwi Veterinary 차트를 더 보려면 여기를 클릭.
Mwi Veterinary (NASDAQ:MWIV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Mwi Veterinary 차트를 더 보려면 여기를 클릭.